Watch ACH. Know when insiders buy.
One email the day a filing lands. Free.
ACH
ACCENDRA HEALTH INC/VA/
1.21
−0.01 −0.82%
USD · close Sep 4
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
6
FLAG · shorts 6
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $93.1MP/E —DIV YIELD —FCF YIELD -383.85%REV TTM $2.6B −3.3%NET INCOME −$302.1MNET DEBT $1B52W 0.95 – 5.55SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $613.2M | −10.1% | 43.0% | −$35.1M | −$89.1M | — | -1.16 | −$26M | $47.6M | −$73.6M | Aug 10 |
| Q1 2026 · Mar 31 | $627.8M | −6.8% | 44.3% | $17.1M | −$6.5M | — | -0.08 | −$50.1M | $41.6M | −$91.7M | Aug 10 |
| Q4 2025 · Dec 31derived | $709M | +2.0% | 45.6% | $20.9M | −$56.3M | — | -0.76 | $68.2M | $13.1M | $55.1M | Feb 20 |
| Q3 2025 · Sep 30 | $697.3M | +1.5% | 46.2% | $26.5M | −$150.3M | — | -1.94 | −$172.5M | $74.4M | −$246.9M | Oct 31 |
| Q2 2025 · Jun 30 | $681.9M | +3.3% | 47.6% | −$39.7M | −$869.1M | — | -11.30 | $37.6M | $57.6M | −$20M | Aug 10 |
| Q1 2025 · Mar 31 | $673.9M | −74.2% | 78.1% | $19.8M | −$25M | — | -0.32 | −$35.1M | $45.8M | −$80.9M | Aug 10 |
| Q4 2024 · Dec 31derived | $695M | — | 83.4% | −$272.7M | −$296.1M | −1765.1% | -3.86 | $71M | $22.3M | $48.7M | Feb 20 |
| Q3 2024 · Sep 30 | $686.8M | −73.5% | 81.5% | $31.1M | −$12.8M | — | -0.16 | $27.3M | $61.5M | −$34.2M | Oct 31 |
| Q2 2024 · Jun 30 | $660.4M | — | 82.4% | $16.9M | −$31.9M | — | -0.42 | $116.1M | $45.8M | $70.3M | Oct 31 |
| Q1 2024 · Mar 31 | $2.6B | — | 20.5% | $9.7M | −$21.9M | — | -0.29 | −$53M | $46M | −$99M | Oct 31 |
| Q4 2023 · Dec 31derived | −$5.1B | — | -11.1% | $88.7M | $17.8M | — | 0.25 | $111.8M | $31.9M | $79.9M | Feb 20 |
| Q3 2023 · Sep 30 | $2.6B | — | 20.8% | $23.8M | −$6.4M | — | -0.08 | $157.4M | $50.6M | $106.8M | Nov 4 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $2.8B | 46.7% | $27.5M | −$1.1B | -39.8% | -14.31 | −$101.8M | $191M | −$292.7M | $10.2M | — |
| FY2024 · to Dec 31 | $2.7B | 82.8% | −$217.7M | −$362.7M | -13.5% | -4.73 | $161.5M | $170.3M | −$8.8M | — | — |
| FY2023 · to Dec 31 | $2.6B | 83.3% | $133.2M | −$41.3M | -1.6% | -0.53 | $740.7M | $172.4M | $568.3M | — | $0 |
| FY2022 · to Dec 31 | $10B | 18.3% | $142.9M | $22.4M | 0.2% | 0.29 | $325M | $158.1M | $166.9M | — | $0 |
| FY2021 · to Dec 31 | $9.8B | 15.5% | $368.5M | $221.6M | 2.3% | 2.94 | $124.2M | $41M | $83.2M | — | $731K |
| FY2020 · to Dec 31 | $8.5B | 15.1% | $204.1M | $29.9M | 0.4% | 0.47 | $339.2M | $50.4M | $288.8M | — | $648K |
Every number comes from ACCENDRA HEALTH INC/VA/'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.